July 1, 2025BreatheOpen Access

Liquid biopsy in lung cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Liquid biopsy detects biomarkers in lung cancer, suggesting a shift towards personalized treatment efforts.

Detecting tumour-derived biomarkers improves early diagnosis and monitoring of lung cancer progression.
Next-generation sequencing identifies actionable mutations in patients with nonsmall cell lung cancer for better outcomes.
Liquid biopsy technologies show promise in overcoming late-stage diagnoses, yet challenges like false positives remain.
Combining multi-omics data with artificial intelligence could enhance precision in lung cancer treatments.

Toland et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark